INTRODUCTION
T he consequences of the use of contaminated endoscopes are a recurrent topic in the endoscopy literature. Flexible endoscopes may become heavily contaminated with blood, secretions, and microorganisms during use. These instruments are difficult to clean and disinfect and easy to damage because of their complex design, with narrow lumens and multiple internal channels ( Fig. 1) (1) . If the instruments are not properly cleaned, the disinfection and drying procedures can fail and increase the possibility of transmission of infection from one patient to another (2) . In addition, the ability of bacteria to form biofilms in the endoscope channels, especially when these become damaged, can contribute to failure of the decontamination process (2, 3) .
Accurate reprocessing of flexible endoscopes is a multistep procedure involving cleaning followed by high-level disinfection (HLD) with further rinsing and drying before storage. Endoscope reprocessing can be performed with the use of automated endoscope reprocessors (AERs) and manual methods. Since almost all outbreaks are related to breaches in reprocessing techniques, it is crucial that endoscope cleaning, disinfection, and drying are performed according to a strict protocol. However, process control of endoscope reprocessing does not guarantee prevention of settlement of biofilm during endoscopy (2) .
Current endoscope reprocessing and infection control guidelines have been reported by various organizations (4) (5) (6) (7) , and under controlled conditions, these measures are adequate. The most common factors associated with microbial transmission involve inadequate cleaning, disinfection, and drying procedures; the use of contaminated AERs; and flaws in instrument design or the use of damaged endoscopes.
Endoscopy-related infections can be divided into two types: endogenous and exogenous. Endoscopic procedures most often result in endogenous infections (i.e., infections resulting from the patient's own microbial flora), and Escherichia coli, Klebsiella spp., Enterobacter spp., and enterococci are the species most frequently isolated (8) . Examples of endogenous infections include pneumonia resulting from aspiration of oral secretions in a sedated patient during flexible bronchoscopy and bacteremia in patients with biliary obstruction during endoscopic retrograde cholangiopancreaticography (ERCP). Endogenous infections are associated with endoscopy but cannot be prevented by well-controlled disinfection procedures (9) . The exogenous microorganisms most frequently associated with transmission are Pseudomonas aeruginosa and Salmonella spp. during flexible gastrointestinal (GI) endoscopy and P. aeruginosa and mycobacteria during bronchoscopy (10) . These microorganisms can be transmitted from previous patients or contaminated reprocessing equipment by contaminated endoscopes or its accessory equipment. Exogenous infection should be prevented by strict endoscope disinfection procedures (9) .
The purpose of this review is to present an overview of the infections and cross-contaminations related to flexible GI endoscopy and bronchoscopy and to illustrate the impact of biofilm on endoscope reprocessing and postendoscopic infection.
PRACTICAL ASPECTS OF FLEXIBLE ENDOSCOPE REPROCESSING

Relevance of Cleaning and Disinfection
According to the Spaulding classification system, medical devices are divided into three categories based on the risk of infection (11) . Critical medical instruments (e.g., surgical instruments and prosthetic heart valves) that enter the vascular system and normally sterile tissues and that carry a high degree of infection risk if contaminated during use should be sterilized. Noncritical medical devices, such as stethoscopes, coming into contact with intact skin require low-level disinfection or simple cleaning with detergent and water. Most flexible endoscopes belong to semicritical devices which come into contact with mucous membranes during use and have a moderate degree of infection risk if contaminated at the time of use. They should receive at least HLD. HLD is a process that eliminates or kills all vegetative bacteria, mycobacteria, fungi, and viruses, except for small numbers of bacterial spores (12, 13) . Sterilization results in the complete destruction of all forms of microbiological life, including bacterial spores.
Flexible endoscopes for therapeutic procedures (bronchoscopy and ERCP) and reusable accessories, such as biopsy forceps, are used in sterile body cavities and should be classified as critical devices (12, 13) . They should be sterilized after each procedure. Due to their material composition, most flexible endoscopes cannot be steam sterilized (9) . They tolerate ethylene oxide and hydrogen peroxide plasma sterilization, which are expensive and are not preferred by most institutions (14) . No data are available demonstrating that sterilization results in a lower frequency of postendoscopic infection than does HLD. Ethylene oxide and hydrogen peroxide plasma sterilization have rapid and reliable efficacy compared to HLD (15) . However, both sterilizers destroy chemical, biological, and mechanical properties of instruments, including flexible endoscopes. Gas sterilization with ethylene oxide may fail in the presence of organic debris after inadequate cleaning (16, 17) and when biofilm has settled in internal endoscope channels (2, 18) .
Natural bioburden levels detected on flexible GI endoscopes range from 10 5 CFU/ml to 10 10 CFU/ml after clinical use (19, 20) . Cleaning must precede HLD or sterilization to remove organic debris (e.g., blood, feces, and respiratory secretions) from the external surface, lumens, and channels of flexible endoscopes (4, 21) . Inadequate cleaning of flexible endoscopes has been frequently associated with microbial transmission during endoscopic procedures. Appropriate cleaning reduces the number of microorganisms and organic debris by 4 logs, or 99.99% (20) .
The manual cleaning procedure for flexible endoscopes includes brushing of the external surface and removable parts (e.g., suction valves) and immersion in a detergent solution followed by irrigation of internal channels with a detergent. The endoscope and accessories should be inspected for damage, and a leak test should be performed before disinfection (4) .
AERs are strongly recommended for reprocessing of flexible endoscopes to document all steps and to minimize contamination and contact with chemicals and contaminated instruments (5) . However, contaminated and defective AERs can result in inadequate reprocessing and contamination of endoscopes and have been associated with outbreaks of endoscopy-related infections (22) (23) (24) (25) (26) . Presence of biofilms in the AERs has been detected during these outbreaks (23, 25, 26) .
Disinfecting agents used for HLD must have bactericidal, mycobactericidal, fungicidal, virucidal, and sporicidal activity (12, 13) . According to their activity against bacteria, fungi, spores, and viruses, disinfectants can be classified into the following three groups: high-level (glutaraldehyde, peracetic acid, and ethylene oxide), intermediate-level (ethanol, formaldehyde, and phenolic solutions), and low-level (povidone-iodine, cetrimide, and benzalkonium chloride) disinfectants (11, 12, 27) . Intermediate-level disinfectants do not have sporicidal activity. Disinfectants with low potency do not destroy Mycobacterium tuberculosis, atypical mycobacteria, and bacterial spores. Concentration and exposure time of a disinfecting agent are crucial; inappropriate dilution and insufficient exposure can result in a failure of effective reprocessing (28) (29) (30) . Inappropriate disinfectants with low and intermediate potency are not recommended for HLD and have been replaced by glutaraldehyde, hydrogen peroxide, ortho-phthalaldehyde, peracetic acid, and superoxidized and electrolyzed acid water (31, 32) . Advantages and disadvantages of commonly used high-level disinfectants are summarized in Table 1 .
Glutaraldehyde (2 to 4%) is a disinfecting agent effective against bacteria, viruses, fungi, and spores that is relatively inexpensive, is noncorrosive to metal, and does not damage endoscopes and processing equipment (5, 33) . Two percent aqueous solutions of glutaraldehyde killed vegetative bacteria in Ͻ2 min, fungi and viruses in Ͻ10 min, and spores of Bacillus spp. and Clostridium spp. in 3 h (33) (34) (35) . However, glutaraldehyde has irritant properties for the respiratory tract, eyes, and skin and can cause allergic reactions, contact dermatitis, and asthma (36) . For these reasons, the use of this high-level disinfectant should be done with containment to minimize aerosolization of glutaraldehyde. Acute colitis occurring after lower GI endoscopy was probably caused by glutaraldehyde residues in the endoscope after disinfection (37) . Other disadvantages of glutaraldehyde are coagulation and fixation of proteins and failure to eliminate atypical mycobacteria within standard contact times (5, 35, 38) . Microorganisms possessing resistance to glutaraldehyde include atypical mycobacteria (Mycobacterium chelonae and Mycobacterium avium complex) (39, 40) and Cryptosporidium parvum (41) . P. aeruginosa resistance to glutaraldehyde was responsible for three separate clinical episodes of ERCP-associated cholangitis (42) . The mechanism of the high biocide resistance of mycobacteria is probably associated with the decreased penetration of a disinfectant through the hydrophobic lipid-rich cell wall (35) . Two percent alkaline glutaraldehyde completely inactivated M. tuberculosis in bronchoscopes after 10 min of incubation (43) . M. avium, Mycobacterium gordonae, and Mycobacterium intracellulare were more resistant to inactivation by 2% alkaline glutaraldehyde and survived the treatment for more than 10 min (38) . Since mycobacteria are more resistant to glutaraldehyde than other bacteria, the manufacturers' instructions for flexible endoscopes and this high-level disinfectant should followed to determine the correct conditions. ortho-Phthalaldehyde (0.55%) is a high-level disinfectant with a noncorrosive to metal (5, 33) Development of biocide resistance (39) (40) (41) (42) Relatively inexpensive (5) Coagulation and fixation of proteins (5) ortho-Phthalaldehyde High biocidal activity (inclusive of mycobacteria) (5, 44) Slow action against bacterial spores (5) Does not damage endoscopes and processing equipment Staining of the skin, clothing, instruments (46) Irritation of the respiratory tract and eyes; development of "anaphylaxis-like" reactions after repeated use (5, 36, 45 ) Expensive
Peracetic acid
Excellent and fast biocidal activity at low concentrations (5, 7) Irritant to the respiratory tract and eyes (5, 7, 36) Can be used at low temperatures (5, 7) Corrosive action depending on the pH value and concn (7) No development of resistance reported Limited efficacy in biofilm removal and in killing bacteria within the biofilm (47) (48) (49) Electrolyzed acid and superoxidized water Excellent and fast biocidal activity (15) Reduced efficacy in the presence of organic soil after inappropriate cleaning (50) Nontoxic to biological tissues; nonirritant to the respiratory tract, eyes, and skin (15) Relatively inexpensive higher mycobactericidal efficacy than glutaraldehyde (5, 44) . Disadvantages of this disinfectant include slow action against bacterial spores, irritation of the respiratory tract and eyes of the patients and staff, and the possibility of causing "anaphylaxis-like" reactions after repeated use (5, 36, 45) . ortho-Phthalaldehyde stains skin, instruments, clothing, and surfaces and is more expensive than glutaraldehyde (46) .
Peracetic acid is an oxidizing agent usually used for HLD of flexible endoscopes in AERs. It rapidly deactivates a large variety of pathogenic microorganisms, viruses, and spores at low concentrations (Ͻ0.3%) (5, 7) . No development of microorganism resistance to peracetic acid has been reported. This disinfectant can be used at low temperatures and causes less irritation than glutaraldehyde but has corrosive action depending on the pH value and concentration (7) . Several disinfectants that contain peracetic acid and hydrogen peroxide are available. Although the biocidal effect of peracetic acid on sessile microorganisms is well known, the effect of this disinfecting agent on microbial biofilms has not been completely studied. A recent study demonstrated insufficient efficacy of 1% peracetic acid disinfectant for 10 min against P. aeruginosa, Stenotrophomonas maltophilia, and Candida sp. biofilms (47) . According to the literature, peracetic acid has the ability to fixate biofilms, and therefore, it can show limited efficacy in biofilm removal from the abiotic surfaces and in killing bacteria within the biofilm (48, 49) . Vigorous cleaning with brushes or agitated liquids is important to remove as much biofilm as possible (4) .
Electrolyzed acid and superoxidized water are relatively new disinfectants used for endoscope reprocessing (15) . These disinfectants are produced by the electrolysis of sodium chloride solutions. They have excellent biocidal activity and are inexpensive, nontoxic to biological tissues, and nonirritating to the respiratory tract, eyes, and skin (15) . However, antimicrobial efficacy can be reduced in the presence of organic soil after inappropriate cleaning (50) .
After the disinfection phase, the remaining disinfectant must be removed from the exterior and from the internal channels by rinsing the endoscope with bacterium-free water. According to the Guideline Committee of the European Society of Gastrointestinal Endoscopy, sterile water is preferable for the final rinse to prevent recontamination (5) . Many outbreaks of endoscopy-related infections and cross-contaminations due to P. aeruginosa, Serratia marcescens, M. chelonae, Mycobacterium xenopi, and Methylobacterium mesophilicum have been related to rinsing flexible endoscopes after disinfection with nonsterile tap water (30, (51) (52) (53) (54) (55) (56) (57) . The accepted procedures to produce bacterium-free water in disinfectors for endoscopes include filtration, UV radiation, or heating followed by cooling (5) . However, major U.S. guidelines recommend the use of sterile, filtered, or tap water to rinse the endoscope channels after HLD, followed by flushing of the endoscope channels with 70% to 90% ethyl alcohol or isopropyl alcohol (6, 7, 21) . The rinse water must be discarded after each cycle. Water bottles used for irrigation during the procedure should be high-level disinfected or sterilized at least daily. Sterile water should be used to fill the water bottle.
Relevance of Drying and Storage
Accurate endoscope drying is crucial, whereas a humid environment facilitates microbial growth during storage. The final drying steps greatly reduce the risk of remaining pathogens as well as the possibility of recontamination of the endoscope by waterborne microorganisms such as Pseudomonas spp. and Acinetobacter spp. (58) . Flexible endoscopes should be dried with filtered compressed air manually or in AERs between endoscopic procedures (a short drying cycle) and at the end of the day (an intensive final drying) (5, 59) . Several guidelines recommend forced air drying, preceded by flushing of the internal channels with 70% to 90% ethanol or isopropanol at the end of a clinic day (6, 7, 21) . Allen et al. (22) showed a high efficiency in preventing P. aeruginosa contaminations by flushing 70% ethanol through endoscope channels followed by drying with compressed air. Due to the fixative properties of ethanol, its use is not recommended in some countries.
Storage is an important factor in the maintenance of bacteriumfree endoscopes. It is recommended that a dust-free drying cabinet be used for endoscope storage, in which the endoscopes are hung vertically (5, 60, 61) . Noy et al. (62) noted that storing the endoscopes vertically in air after cleaning until the next use of the endoscope resulted in a drop of the contamination rate from 35 to 0%. According to the literature, endoscopes stay bacterium free after prolonged storage if an adequate drying procedure is applied (60, 61) . When stored in the drying cabinet with a laminar airflow, no growth of bacteria and Candida spp. was found in endoscope channels 5 days after reprocessing (61). Low levels of microbial contamination on endoscopes stored in the drying and storage cabinet were detected, compared with the stable or increased microbial numbers on endoscopes stored outside the cabinet (60) .
Many outbreaks of health care-associated infection after endoscopy and cross-contaminations due to P. aeruginosa, S. marcescens, M. tuberculosis, and M. chelonae have been associated with drying of flexible endoscopes without ethanol flushing or lack of a drying procedure (22-24, 30, 52, 57, 63-76) .
EXOGENOUS INFECTIONS ASSOCIATED WITH FLEXIBLE ENDOSCOPY
Despite the large number of endoscopic procedures that are performed annually, documented data suggest that postendoscopic iatrogenic infections are rare. In GI endoscopy, the estimated rate of health care-associated infection is approximately 1 out of 1.8 million procedures (77) . However, the true rate of transmission during endoscopy may go unrecognized because of technically inadequate surveillance, no surveillance at all, low frequency, or the absence of clinical symptoms (2, 9) . Two hundred eighty-one patients infected after GI endoscopy were found in studies of endoscopy-related infections between 1966 and 1992 in the United States (8) . Gorse and Messner (14) reported 6% iatrogenic infections after GI endoscopy in 116 hospitals. During the period of 1974 to 2004, 30 outbreaks of endoscopy-related infections and cross-contaminations involving 251 patients infected after GI endoscopic procedures were reported in the United States (78) . Inadequate decontamination procedures and equipment malfunction were two leading causes of postendoscopic infection and contamination. More than 91% of the infections identified could be prevented if quality control systems were improved.
The important risk factors of infections in GI endoscopy are the number of microorganisms present inside the endoscope or the growth of a biofilm, invasive endoscopic procedures resulting in tissue damage, compromised immune status of the patient (human immunodeficiency virus [HIV] infection, neoplastic diseases, transplant patients, and immunosuppressive treatment), and the presence of infective foci (abscess and cholangitis) during an endoscopic procedure (79) (80) (81) .
An overview of the exogenous endoscopy-related infections and cross-contaminations after flexible GI endoscopy and bronchoscopy is presented in Tables 2 to 5.
Bacteria
Salmonella spp. In the past, Salmonella spp. were the most common microorganisms associated with infections transmitted by GI endoscopy (28, (82) (83) (84) (85) (86) (87) (88) . Many Salmonella outbreaks were related to an inappropriate use of disinfectants with intermediate and low potency instead of high-level disinfecting agents (Tables 2 and 3 ). There have been no reports of Salmonella infection since the current guidelines for HLD have been followed.
The following Salmonella serotypes were isolated from contaminated endoscopes or accessories: Salmonella enterica serotypes Typhi (84) , Typhimurium (28, 82) , Agona (88), Goerlitz (28) , Newport (85), Oslo (83), Kedougou (86) , and Lomita (87) . A minority of patients involved were asymptomatic carriers and had stool or urine cultures positive for Salmonella spp. Salmonella infections developed within 1 to 9 days after a GI endoscopic procedure and included acute gastroenteritis (28, 82, 83, 85, 86) , peritoneal abscess (82) , urinary tract infection (28) , and bacteremia/ sepsis (83, 84, 88) .
Pseudomonas aeruginosa. P. aeruginosa, a Gram-negative opportunistic pathogen, is the most commonly reported microorganism responsible for transmission of infection during GI endoscopy and bronchoscopy. It is known for its preference for a moist environment (hospital water supply and wet endoscope channels after reprocessing) (10) . Pseudomonas is able to form biofilms, and these biofilms are extremely difficult to remove from plumbing, AERs, and endoscope channels (2, 89) . Serotype 10 of P. aeruginosa predominates in the published reports of Pseudomonas transmission (22, 23, 53, 73, 90, 91) . It is possible that slime production by P. aeruginosa serotype 10 in a biofilm can form a barrier to antibiotics and disinfectants and lead to antibacterial resistance, but no explanation was offered as to why specifically this serotype was isolated.
Among healthy adults, P. aeruginosa can colonize many body sites, as evidenced by isolation from throat, sputum, and stool (92) . Hospitalized patients, as well as patients with certain chronic lung diseases, have higher colonization rates. During health carerelated outbreaks, Pseudomonas transmission can result in colonization of involved patients in the GI and respiratory tract with an absence of clinical symptoms and negative blood cultures, which was determined by molecular typing (93) . Severe health care-associated postendoscopic infections due to P. aeruginosa include sepsis, liver abscess, and ascending cholangitis after flexible GI endoscopy (particularly after ERCP) and bloodstream infection and pneumonia after bronchoscopy. Post-ERCP P. aeruginosa infectious complications occur most frequently in patients with biliary obstruction undergoing endoscopic biliary stenting (94) .
Many outbreaks of P. aeruginosa infection after GI endoscopy and bronchoscopy have been associated with inadequate cleaning and the use of inappropriate intermediate-level and low-level disinfectants (29, 62, 64, 73, 80, 90, (95) (96) (97) (98) , contaminated endoscope water bottles and the water supply to the endoscope (29, 65, 90, 99, 100) , and drying of endoscope channels with no flushing with 70% ethanol after disinfection (22, 30, 70, (73) (74) (75) or lack of a drying procedure (26, 64) (Tables 2 to 5 ). Two recent outbreaks of multidrug-resistant P. aeruginosa post-ERCP infections have been related to the remaining contamination of the endoscope despite accurate reprocessing followed by negative surveillance endoscope cultures (2, 101) . In an outbreak of post-ERCP sepsis described by Kovaleva et al. (2) , the implicated endoscope was repetitively found to be positive by culturing for multidrug-resistant P. aeruginosa after HLD and contained biofilm in undamaged inner channels. The P. aeruginosa isolates from patients and the implicated endoscope underwent molecular typing and showed matching patterns.
Several postendoscopic P. aeruginosa outbreaks have been related to contaminated or defective AERs (22, 23, 26, 74, 75, 102, 103) , the use of incorrect connectors between the endoscope and AER (103, 104) , and defective endoscopes and accessories (93, (105) (106) (107) (Tables 2 to 5 ). The presence of biofilm deposits on the internal plumbing and detergent tank of AERs resulted in two outbreaks (23, 26) .
In most outbreaks, the Pseudomonas strains obtained from patients were identical to those recovered from endoscopes, as determined by comparison of antimicrobial sensitivity patterns of the isolates, serotyping, and phage typing or by more recently developed molecular techniques (90, 97) .
Mycobacteria. M. tuberculosis and nontuberculous mycobacteria are microorganisms frequently associated with health care-associated transmission during endoscopic procedures, particularly during bronchoscopy. While transmission of nontuberculous mycobacteria is usually associated with contaminated AERs and rinsing water, contamination with M. tuberculosis generally comes from an infected patient during an endoscopic procedure (8) . Most outbreaks due to nontuberculous mycobacteria have involved rapidly growing M. chelonae, intermediately growing M. gordonae, and slowly growing M. xenopi and M. avium complex strains.
Most publications about mycobacterial outbreaks described cross-contamination, a situation where the patient becomes nosocomially colonized with a strain from the endoscope in the absence of infection, but reports of bronchoscopy-related pulmonary tuberculosis were documented (63, (108) (109) (110) (111) . The majority of the patients was immunocompromised and had a history of lung cancer, HIV, or hematological malignancies. Most M. tuberculosis isolates were susceptible to antituberculosis drugs, but health care-associated transmission of multidrug-resistant tuberculosis has been reported (63) . Nontuberculous mycobacteria, such as M. chelonae, M. avium, M. xenopi, M. gordonae, and M. fortuitum, can form the risk for development of colonization or infection in severely immunocompromised patients (112, 113) .
The effectiveness of disinfectants against mycobacteria depends on the composition and concentration of the active agent, contact time, and presence of organic material (27, 113, 114) . Activities of different disinfectants against M. tuberculosis and nontuberculous mycobacteria were tested in several studies. van Klingeren and Pullen (115) showed inadequate tuberculocidal activity of quaternary ammonium, good activity of phenolic disinfectants, and rapid killing of M. tuberculosis with 70% ethanol and 60% isopropanol. High-level effectiveness of 2% glutaraldehyde against M. tuberculosis and M. chelonae was demonstrated directly after cleaning and after 10-and 20-min exposures (43, 116, 117) . Peracetic acid (0.26%) was effective against M. tuberculosis and M. avium complex strains within 10 to 20 min, with a 5-log reduction in viable bacteria (118) . Mycobacteria are known to possess resistance to many disinfecting agents, including aldehydes (35, 119) . The mechanism of the high-level biocide resistance of mycobacteria is not completely understood; most likely, it is associated with decreased penetration of a disinfectant through the hydrophobic lipid-rich cell wall (35) . Nontuberculous mycobacteria tend to be more resistant to antiseptics and disinfectants than M. tuberculosis (113) . Slowgrowing M. avium complex and intermediately growing M. gor-donae strains survived treatment with 2% glutaraldehyde for more than 10 min (38) . The M. chelonae strain resistant to glutaraldehyde and peracetic acid was isolated from a contaminated AER (40) . Nomura et al. (39) reported a high percentage of glutaraldehyde-tolerant M. chelonae strains which were either resistant or intermediately resistant to 2 or 3 classes of antibiotics.
Most outbreaks of M. tuberculosis and nontuberculous mycobacterium transmission have been associated with inadequate cleaning, disinfection, and drying procedures (24, 27, 51, 52, 63, 66, 68, 71, 76, 104, 108, 109, 120) , contaminated AERs and contaminated tap water used to rinse bronchoscopes after disinfection (24, 25, 51, 52, 56, 68, 71, 76, (121) (122) (123) , and defective or contaminated endoscopes and accessories (104, 110, 111, 120, (124) (125) (126) (127) (Tables 4 and 5 ). The presence of M. chelonae and M. mesophilicum biofilms was found in a contaminated AER during one outbreak (25) . Helicobacter pylori. Although Helicobacter pylori is a common pathogen in patients with chronic gastritis, peptic ulcer, and gastric cancer, transmission of H. pylori by GI endoscopy is rare. Langenberg et al. (128) documented a 1.1% risk of endoscopic transmission of H. pylori in patients. Tytgat (129) estimated the frequency of transmission to be approximately 4 per 1,000 endoscopic procedures when the infection rate in the population was about 60%. However, the true incidence of H. pylori transmission may be underestimated because of the high prevalence of Helicobacter infection in the examined patient population and the asymptomatic or nonspecific clinical presentation of H. pylori infection (129) .
H. pylori transmission was recognized with the introduction of new molecular techniques and was first demonstrated by using restriction enzyme DNA analysis (128, 130) . Three H. pylori outbreaks after upper GI endoscopy were related to inadequate reprocessing of endoscopes and not-sterilized biopsy forceps (128, 130, 131) . Four patients involved in these outbreaks developed postendoscopic gastritis.
Although H. pylori is readily killed by most disinfectants, including glutaraldehyde, povidone-iodine, and benzalkonium chloride, within 15 to 30 s (132), 70% ethanol failed to disinfect endoscopes between uses in patients (128) . Disinfection with 2% glutaraldehyde for 5 and 10 min was effective in eliminating H. pylori DNA from flexible endoscopes (133, 134) .
Clostridium difficile. C. difficile, an obligatory anaerobic, spore-forming, Gram-positive rod, is responsible for a number of different intestinal diseases and is transmitted from patient to patient through the oral ingestion of its vegetative cells or endospores (135) . Only one report of possible C. difficile transmission with development of fulminant pseudomembranous colitis after colonoscopy has been published (136) . Thus, the risk of development of C. difficile-associated diarrhea after GI endoscopy is very low (137) .
Commonly used high-level disinfectants have been studied to assess whether the vegetative cells and endospores of C. difficile are destroyed during different exposure times. Two percent glutaraldehyde and peracetic acid are capable of destroying large numbers of C. difficile endospores using exposure times of 5 to 20 min (138) (139) (140) .
Other microorganisms. Many health care-associated S. marcescens outbreaks have been related to inadequate disinfection and drying procedures (30, 55, 57, 72, 141, 142) and rinsing of endoscope channels with nonsterile tap water after disinfection (30, 55, 57) (Tables 4 and 5) . A postbronchoscopic outbreak involved 117 patients who were colonized with different Enterobacteriaceae and was associated with two specific bronchoscopes contaminated with Klebsiella pneumoniae and Proteus vulgaris (143) .
Duodenoscope-related nosocomial infections due to extended-spectrum-␤-lactamase (ESBL)-producing and K. pneumoniae carbapenemase (KPC-2)-producing K. pneumoniae have been detected in two French hospital outbreaks (144, 145 producing ESBL type CTX-M-15 was isolated from patients with post-ERCP sepsis and cholangitis (144) . One duodenoscope was indicated as the source of patient-to-patient transmission. Environmental cultures from the AERs and surfaces of the endoscopy rooms and routine surveillance cultures from endoscopes were negative. In the second outbreak, transmission of KPC-2-producing K. pneumoniae was associated with the use of a contaminated duodenoscope that had previously been used to examine an index patient transferred from a Greek hospital (145) . An incomplete drying procedure was detected during endoscope reprocessing.
Methylobacterium is a slow-growing, pink-pigmented, Gramnegative rod and is a common contaminant in water (146) . Crosscontaminations of Methylobacterium in patients by contaminated bronchoscopes have been related to contaminated tap water in the bronchoscopy unit and to biofilm-containing AERs (25, 54) . It was considered a colonizer because no patient manifested true infection with this bacterium. Only one case of Methylobacterium bacteremia in a patient after ERCP and removal of a biliary tract prosthesis has been reported (147) . Methylobacterium has a strong biofilm-producing ability and is highly resistant to dehydration, elevated temperatures, and ionizing radiation, which can explain the frequent occurrence and colonization of Methylobacterium in the hospital environment (148, 149) .
A wide variety of other pathogens can be transmitted during endoscopic procedures. Health care-associated transmission of Strongyloides stercoralis (150) , Trichosporon spp. (151, 152) , and the yeast Rhodotorula rubra (69, 153) have been reported. Crosscontaminations of Blastomyces dermatitidis (154) , Legionella pneumophila (155) , and Bacillus spp. (156) after flexible bronchoscopy were related to inadequate cleaning and disinfection and a contaminated suction valve of the instrument.
The sensitivity of many unusual pathogens to disinfecting agents is mainly unknown. La Scola et al. (157) reported that HLD with 2% glutaraldehyde or peracetic acid disinfectants for 20 min may be ineffective to prevent transmission of Tropheryma whipplei by GI endoscopes. According to Muscarella (158) , 2% glutaraldehyde and gas sterilization with ethylene oxide are able to destroy the vegetative cells and endospores of Bacillus anthracis. Transmissible cysts of intestinal protozoa such as Giardia intestinalis and Cryptosporidium are highly resistant to many disinfectants, including chlorine (159) and 2% glutaraldehyde (160) .
Viruses
Hepatitis B virus. Hepatitis B virus (HBV) is a highly infectious
DNA virus that is easily transmitted through contact with blood or body fluids of an infected person. Despite the high infectivity of hepatitis B, only one case of endoscopic HBV transmission confirmed by molecular analysis has been documented after gastroscopy (161) . Two other reports described HBV transmission in two patients after GI endoscopy with an instrument used in HBVpositive patients (162, 163) . Both patients became HBsAg positive 9 months after endoscopy. Subtyping of the virus was not performed. The implicated endoscopes were inadequately disinfected between procedures.
Several clinical studies monitored patients after GI endoscopic procedures performed with an endoscope used during a preceding procedure in HBV-positive patients (164) (165) (166) (167) (168) (169) (170) (171) . No evidence of subsequent HBV infection related to the previous endoscopy was found, confirming that HBV transmission is not associated with GI endoscopy when appropriate disinfection procedures are performed.
Two studies have examined the sensitivity of HBV to disinfectants, including 2% glutaraldehyde at 20°C for 10 min and 80% ethanol at 11°C for 2 min, and heating at 98°C for 2 min (172, 173) . All treatments were shown to be effective, indicating that the resistance level of HBV is not extreme.
Hepatitis C virus. Hepatitis C virus (HCV) is a small, enveloped RNA virus that can be transmitted through contact with infected blood or body fluids during diagnostic and therapeutic invasive procedures (174) . The overall risk for HCV transmission through GI endoscopy is controversial. Several studies found that GI endoscopic procedures were associated with HCV infection (175) (176) (177) (178) . Other clinical studies monitored HCV-negative patients who underwent GI endoscopy with the same endoscopes as those used on HCV-positive patients (179, 180) . It was concluded that the risk for HCV transmission by endoscopy is low when adequate endoscope reprocessing is used.
Several cases of patient-to-patient HCV transmission have been related to inadequate cleaning and disinfection of GI endoscopes and accessories (181) (182) (183) (184) and to the use of contaminated anesthetic vials or syringes (182, 183) . In two cases, genotyping and nucleotide sequencing of the viral isolates showed the same HCV strain (181, 182) .
Ciesek et al. (185) examined the sensitivity of HCV to hand antiseptics, high-level disinfectants, and high temperatures. Glutaraldehyde (0.5%) and 0.05% peracetic acid were able to completely inactivate HCV within 1 min of incubation. A Ͼ100-fold reduction of infectivity was observed after 5 min of exposure of the virus to 75°C.
HIV. Recognition of the viral etiology of AIDS in 1983 led to great concern about possible health care-associated transmission of the virus. HIV might be inoculated during trauma into GI mucosa, for example, during insertion of a contaminated endoscope.
No cases of HIV transmission attributed to endoscopy have been reported so far. The virus is sensitive to many disinfectants, including 70% ethanol and 2% glutaraldehyde (186) . Sampling of 20 gastroscopes immediately after use in patients with AIDS and before disinfection found contamination with commensal bacteria, P. aeruginosa, Candida albicans, HBV, and, in 35% of cases, HIV (187) . Bronchoscopes were less heavily contaminated: HIV, HBV, commensal bacteria, and Pneumocystis jirovecii were detected by culturing, immunofluorescence tests, and PCR after bronchoscopy of patients with pulmonary manifestations of AIDS (187) . Disinfection with 2% glutaraldehyde for 2 min completely eliminated HIV from the endoscopes artificially contaminated with high levels of virus (188) .
Enteroviruses. Enteroviruses are nonenveloped viruses that are more resistant to chemical disinfectants than enveloped viruses. No cases of endoscopic transmission of enteroviruses have been reported. Narang and Codd (189) found that 2% glutaraldehyde reduced poliovirus titers by at least 6 logs within a 30-min test period. Hanson et al. (190) studied elimination of enterovirus by 2% glutaraldehyde from endoscopes artificially contaminated with high virus levels. Samples were virus free after 2 min of disinfection. Virus dried on surfaces was inactivated in 1 min by 2% glutaraldehyde, with a reduction of Ͼ6 logs. Thus, disinfection was effective against a heavy contamination of endoscopes with enterovirus.
Creutzfeldt-Jakob Disease (Prion Disease)
Creutzfeldt-Jakob disease (CJD) and other transmissible spongiform encephalopathies are lethal degenerative neurological disorders with symptoms including dementia, ataxia, myoclonus, and pyramidal and extrapyramidal damage (191) . These degenerative encephalopathies are transmitted by infectious agents called prions (protein particles without nucleic acid) and are characterized by accumulation and different distribution of the specific prion protein in the human body. CJD occurs in new-variant and classical (sporadic and iatrogenic) forms. Iatrogenic CJD followed administration of cadaveric human pituitary hormones (192, 193) , dural graft transplants (194) , corneal transplants (195) , and the use of contaminated neurosurgical instruments (196) .
In classical CJD, prion protein is concentrated in the central nervous system and is found less often in other organs (191) . Intestinal tissue, blood, and saliva have a low risk for transmission of classical CJD. In new-variant CJD, large amounts of the prion protein are accumulated in lymphoid tissue, including the GI tract (197) . Therefore, new-variant CJD transmission via a GI endoscopic procedure remains theoretically possible (198) , but no reports of such transmission have been noted in the literature (199) .
Prions are highly resistant to routine methods of decontamination and sterilization and can remain infectious for years (200) . Dry heat, glutaraldehyde, and ethylene oxide were concluded to be ineffective disinfection and sterilization methods for medical devices (201, 202) . Recommended chemical methods include a decontamination step with concentrated sodium hydroxide, sodium hypochlorite, or formic acid and prolonged steam sterilization (200, 203, 204) . Most contemporary flexible endoscopes cannot be heat sterilized and disinfected with high concentrations of disinfectants without severe damage (1, 9) . Therefore, flexible endoscopes should be discarded after endoscopy in patients with CJD (205) .
ENDOGENOUS INFECTION ASSOCIATED WITH FLEXIBLE ENDOSCOPY Flexible Gastrointestinal Endoscopy
Diagnostic and therapeutic upper gastrointestinal endoscopy.
Bacteremia occurs when the mucosal membrane is damaged (for example, during tooth cleaning). Microscopic tissue trauma occurring during endoscope insertion can result in transient bacteremia. In this case, microorganisms isolated from blood cultures belong to the oropharyngeal commensal microflora and are generally of low pathogenicity (206) .
The reported incidence of bacteremia after diagnostic upper GI endoscopy, with or without biopsies, was less than 8% (207) (208) (209) (210) (211) (212) (213) (214) (215) . The isolated microorganisms included mainly Staphylococcus epidermidis and Streptococcus spp. No infectious complications were detected in patients with bacteremia in a follow-up study 6 months to 2 years after endoscopy.
Therapeutic upper GI endoscopy, including esophageal sclerotherapy, variceal ligation, and esophageal dilatation, is associated with significantly more tissue trauma than diagnostic endoscopy (216) . These endoscopic procedures are frequently performed in the setting of acute bleeding or a benign or malignant stricture of the esophagus and have a higher rate of bacteremia (30%) than diagnostic endoscopic procedures (12.5%) (214) . The incidence of transient bacteremia ranges from 0% to 53% after esophageal sclerotherapy (65, (217) (218) (219) (220) (221) (222) (223) (224) (225) , from 1% to 25% after endoscopic variceal ligation (211, 217, 219, 226) , and from 2% to 54% after esophageal dilatation (227-230).
Other reported infectious complications after upper GI endoscopy include endocarditis of native and prosthetic valves (231-239), meningitis and/or cerebral abscess (240-245), and bacterial peritonitis (222, 246, 247) . The majority of isolated organisms were Streptococcus viridans and Staphylococcus spp.
Colonoscopy and sigmoidoscopy. Microorganisms found in the colon include anaerobic bacteria (Bacteroides fragilis and Clostridium spp.), Enterobacteriaceae (E. coli, Klebsiella spp., Enterobacter spp., and Proteus spp.), and enterococci (248) . The reported incidence of bacteremia after colonoscopy, with or without biopsies and polypectomies, ranges from 0% to 25% (249) (250) (251) (252) (253) (254) (255) (256) (257) . In immunocompetent patients, bacteremia during or after lower GI endoscopic procedures is usually transient and asymptomatic. Duration of colonoscopy with or without biopsy and/or polypectomy does not appear to increase the rate of bacteremia (253, 254) . The incidence of transient bacteremia after flexible sigmoidoscopy ranges from 0% to 1% (258) (259) (260) .
Other infectious complications after colonoscopy and sigmoidoscopy include acute appendicitis (261) (262) (263) (264) (265) (266) (267) , bacterial peritonitis (268, 269) , endocarditis (270) (271) (272) (273) , and septicemia (274) (275) (276) (277) . Two cases of Listeria monocytogenes meningitis and septicemia (278, 279) and one case of Fournier's gangrene of the perineum have been described (280) . The most commonly isolated microorganisms are enterococci, Enterobacteriaceae, and Bacteroides spp.
Percutaneous endoscopic gastrostomy. The most common complication of percutaneous endoscopic gastrostomy is peristomal wound infection, with the rate varying between 3% and 32% (281) (282) (283) (284) (285) (286) . The high risk of wound infection can be explained by contamination of the wound with oropharyngeal microflora during placement of a tube. More severe complications include necrotizing fasciitis (287) (288) (289) , abdominal abscess, peritonitis, and septicemia (281, (290) (291) (292) (293) (294) (295) . The most common infecting organisms are Staphylococcus aureus, Gram-negative bacteria (Klebsiella spp., Enterobacter spp., and P. aeruginosa), enterococci, and C. albicans (291, 295) .
Endoscopic retrograde cholangiopancreaticography. ERCP is an endoscopic procedure associated with an incidence of severe infectious complications of between 2% and 4%, including sepsis, ascending cholangitis, liver abscess, acute cholecystitis, and infected pancreatic pseudocyst (296) (297) (298) (299) . A complication of ERCP can be defined as any event following the 30-day period after endoscopy that changed the health status of a patient negatively (300) . Post-ERCP complications can be divided into mild (up to 3 days in the hospital), moderate (4 to 10 days of hospitalization), and severe (more than 10 days of hospitalization, surgical intervention, and/or death) complications. The important risk factors for post-ERCP infections are exogenous (because of contamination of endoscopes and accessory equipment) and endogenous patient-related factors, including obstruction of the bile or pancreatic duct, tissue damage during the procedure, and compromised immune status (2, 18, 75, 81, 99) .
The rate of occurrence of bacteremia ranges from 0% to 15% after ERCP of unobstructed pancreatic or bile ducts (96, (301) (302) (303) (304) and from 0% to 27% in patients with biliary obstruction by stones or a tumor (302) (303) (304) (305) (306) (307) . Not all bacteremic episodes result in a clinically relevant complication. ERCP-related sepsis is one of the most serious complications of this procedure, with a reported mortality rate as high as 29.4% despite the use of antibiotic therapy (307) . The incidence of post-ERCP sepsis varies from 0.25% to 5.4% in different patient populations (296, 305, (308) (309) (310) (311) and is significantly higher in patients with malignant biliary obstruction than in those with benign obstruction (21% versus 3%) (312) .
Ascending cholangitis results mainly from inadequate drainage of an infected and obstructive biliary duct system (96) . The rate of cholangitis after ERCP varies from 0.08% to 5% (296) (297) (298) (299) (313) (314) (315) (316) (317) (318) (319) (320) (321) (322) . Post-ERCP cholangitis is defined by a typical clinical picture (temperature of Ͼ38°C, upper abdominal colicky pain, and cholestasis/jaundice) without evidence of other concomitant infections and with or without positive bile cultures obtained during biliary drainage (299) . The most frequent organisms responsible for cholangitis/sepsis are enteric bacteria, including Enterobacteriaceae (E. coli, Klebsiella spp., and Enterobacter spp.), enterococci, and a variety of species of alpha-hemolytic streptococci (302, 306, 323) .
Post-ERCP cholangitis is also a frequent complication of a biliary endoprosthesis insertion and occluded stents (323) . Thus, stent removal and replacement frequently occur as a consequence of blockage caused by biofilm growth in the stent lumen (324) . Enterococci, the most common organisms identified from patients with stents, are frequently isolated from infected bile in association with other microorganisms (323) . Leung et al. (325) demonstrated a synergism between E. coli and enterococcal infection: colonization of a stent with E. coli facilitated attachment and biofilm formation by enterococci.
Other post-ERCP infectious complications include acute cholecystitis, with incidences ranging from 0.1% to 5.9% (296-299, 314, 321, 326, 327) ; liver abscess (296, 298, 328, 329) ; and infection of pancreatic pseudocysts (297, 314) .
Antibiotic prophylaxis in flexible gastrointestinal endoscopy. The purpose of antibiotic prophylaxis during GI endoscopy is to reduce the risk of iatrogenic infectious complications. Prophylactic antibiotic administration is not recommended for all GI endoscopic procedures (330) . Therapeutic ERCP, percutaneous endoscopic gastrostomy, esophageal sclerotherapy, variceal ligation, and esophageal dilatation are endoscopic procedures associated with the highest rates of bacteremia and other infectious complications (216) . Regimens of antibiotic prophylaxis for GI endoscopic procedures are summarized in Table 6 .
Percutaneous endoscopic gastrostomy is associated with a high risk of development of wound infection at the gastrostomy site (331) . Prophylactic administration of antibiotics reduced the relative and absolute risk of wound infection by 73% and 17.5%, respectively, and is recommended for all patients undergoing percutaneous endoscopic gastrostomy (285, 331) . The American Society for Gastrointestinal Endoscopy (ASGE) and the Endoscopy Committee of the British Society of Gastroenterology recommend antibiotic prophylaxis with an antibiotic that provides coverage of cutaneous microorganisms, such as a narrow-or expanded-spectrum cephalosporin or amoxicillin-clavulanate, for patients undergoing percutaneous endoscopic gastrostomy, 30 min before the procedure (332, 333) . Therapeutic upper GI endoscopic procedures associated with a high rate of postprocedure bacteremia and peritonitis include esophageal sclerotherapy, variceal ligation, and esophageal dilatation. Prophylactic administration of antibiotics is recommended for all patients with cirrhosis and acute variceal bleeding before esophageal sclerotherapy and variceal ligation and for patients with benign or malignant esophageal strictures before esophageal dilatation (333) . A recent meta-analysis of 12 trials indicated a significant beneficial effect of antibiotic prophylaxis compared with placebo and no prophylaxis in decreasing the incidence of bacterial infections, bacteremia, pneumonia, spontaneous peritonitis, and mortality from bacterial infections in cirrhotic patients with GI bleeding (334) . These benefits were observed independently of the antibiotic used. Administration of a broad-spectrum cephalosporin or piperacillin-tazobactam in a single dose or three doses during 1 day is recommended by the ASGE and the British Society of Gastroenterology (332, 333) .
Recent studies examining antibiotic prophylaxis prior to ERCP concluded that it may reduce the incidence of bacteremia but did not reduce the incidence of clinical sepsis or cholangitis, and therefore, routine use of antibiotic prophylaxis cannot be recommended (300, 335, 336) . Antibiotic prophylaxis is recommended before an ERCP in patients with biliary obstruction (e.g., primary sclerosing cholangitis and/or hilar cholangiocarcinoma) when complete biliary drainage is unlikely to be achieved and in patients with communicating pancreatic cysts or pseudocysts for prevention of cyst infection (332, 333) . An adequate biliary drainage will prevent postprocedure cholangitis or sepsis without prophylactic administration of antibiotics. Continuation of antibiotics after ERCP in patients with biliary complications after liver transplantation may be beneficial, even when drainage is achieved (332, 333) . Prophylactic antibiotics should cover biliary flora such as Enterobacteriaceae, Bacteroides spp., P. aeruginosa, and enterococci. An optimum benefit of antibiotics is obtained if therapeutic levels are present in the tissues at the time of the endoscopic procedure. Antibiotic prophylaxis should be started orally or intravenously at least 1 to 2 h before the procedure. Oral ciprofloxacin, intravenous piperacillin-tazobactam, or gentamicin is recommended (332, 333) . Increasing microbial resistance (ciprofloxacin), poor penetration into bile (gentamicin), and limited activity against enterococci (gentamicin and ciprofloxacin) are disadvantages of these antibiotics. According to the British Society of Gastroenterology, for patients undergoing ERCP with biliary complications after liver transplantation, these antibiotics should be combined with amoxicillin or vancomycin to target Enterococcus spp. (333) . However, local incidence of amoxicillin-resistant, vancomycin-sensitive enterococci and known colonization with vancomycin-resistant enterococci need to be considered. In hospitals with an increasing frequency of vancomycin-resistant enterococci, teicoplanin is recommended in preference to vancomycin for two reasons: first, it is simpler and quicker to administer, and second, more sustained blood levels occur following a single dose (337) .
Antibiotic administration for prevention of infective endocarditis (in patients with cardiovascular risk factors) and graft and device infections (in patients with synthetic vascular graft and other cardiovascular devices) before GI endoscopy is no longer recommended by the ASGE and the American Heart Association (332, 338) . This recommendation is based on an absence of clinically significant evidence of infective endocarditis and device in-fection being associated with GI procedures and on an absence of a conclusive link between GI endoscopy and development of any other type of infection (332) . Antibiotic prophylaxis of septic arthritis during GI endoscopy is not recommended for patients with orthopedic prostheses. However, prophylactic antibiotic administration can be considered prior to any therapeutic GI endoscopic procedure in patients with a seriously impaired immune status (e.g., in cases of neutropenia and hematological malignancy) (333) .
Flexible Bronchoscopy
Oropharyngeal microorganisms from the upper respiratory tract can be carried down into the lower respiratory tract during insertion of a bronchoscope into the lung through the mouth and can penetrate into the bloodstream. These microorganisms include viridans group streptococci, staphylococci, Moraxella spp., Neisseria spp., and anaerobic bacteria (103) .
Bacteremia following bronchoscopy, with or without biopsy, is transient and occurs in Ͻ5% of patients (339) (340) (341) (342) (343) . The microorganisms most frequently isolated from positive blood cultures are staphylococci and beta-hemolytic and viridans group streptococci, which are part of the normal upper airway flora. Fever after bronchoscopic procedures has been reported in many studies with a wide range of frequencies, from 0% to 27% (341, (343) (344) (345) (346) (347) (348) (349) . Reported fevers were transient, developed during the first day after bronchoscopy, and were not associated with septic complications. One possible mechanism of development of fever after bronchoscopy is the release of proinflammatory cytokines from alveolar macrophages (350) .
Pneumonia following bronchoscopic procedures has been reported, with a frequency of 0.6% to 6% (345, 346) . Postbronchoscopy pneumonia was defined as the development of fever and a new or progressive infiltrate on a chest radiograph with peripheral leukocytosis and elevated levels of the C-reactive protein after the procedure. Several cases of fatal pneumonia, long abscess, and sepsis following bronchoscopy with isolation of Streptococcus pneumoniae, E. coli, Haemophilus influenzae, and Cryptococcus sp. from positive blood cultures and bronchial specimens have been described (351) (352) (353) (354) (355) .
Antibiotic prophylaxis is not recommended during flexible bronchoscopy with or without biopsy because of the low incidence of bacteremia and endocarditis (356, 357) . Only one case report of infective endocarditis following bronchoscopy in an HIV-positive patient with mitral valve prolapse has been published (358) . The American Heart Association does not recommend antibiotic prophylaxis for routine flexible bronchoscopy (357) . However, administration of 2.0 g amoxicillin orally 1 h prior to bronchoscopy is recommended for rigid bronchoscopy, particularly for high-risk patients, including patients with prosthetic cardiac valves, previous bacterial endocarditis, and complex cyanotic congenital heart disease (e.g., tetralogy of Fallot) (357) . The British Thoracic Society Bronchoscopy Guidelines Committee recommends prophylactic administration of antibiotics before bronchoscopy for patients who are asplenic, have a heart valve prosthesis, or have a history of endocarditis (356) .
IMPACT OF BIOFILM ON ENDOSCOPE REPROCESSING
Microorganisms in nature do not generally grow in nutrient-rich suspensions (the so-called planktonic state) as in the laboratory but prefer to grow in surface-associated communities called bio-films. A biofilm is an assemblage of microbial cells that is irreversibly attached to a surface and enclosed in a matrix of exopolymeric substances (359) . A typical biofilm will contain around 85% polymeric substances and only 15% bacterial mass, and cells are located in matrix-enclosed "towers" and "mushrooms" (Fig. 2 ) (360, 361) . Biofilms may form on different surfaces, including living or dead tissues, medical devices, water supply systems, or endoscope channels (89, 359) . Biofilm formation by microorganisms on inert surfaces has been extensively studied, and there is a direct relationship between the ability of the organism to form a biofilm and its pathogenicity (362) . Many bacteria, including P. aeruginosa and atypical mycobacteria, are capable of existing in a planktonic state and can produce biofilms.
Bacteria growing within biofilms have a number of characteristics that distinguish them from planktonic populations. The ability to form biofilms allows microorganisms to survive under conditions of drying and chemical and antibiotic exposure (363, 364) . Microorganisms in biofilms are protected from the host immune system and may be 1,000 times more resistant to antibiotics than planktonic cells (365) . The increased resistance to antimicrobial agents can be explained by poor penetration of an antibiotic into a biofilm, low growth rate, and formation of resistant phenotypes of microorganisms within biofilms (363, 364) .
Under adverse conditions, biofilms are capable of releasing their bacterial population into a planktonic state. This ability can be explained by intercellular communication within a biofilm (366) . Signaling systems include quorum sensing (the release of chemical signals in response to increasing population density), biosignal blockers, pheromones, and butyrylhomoserine lactone. These signaling systems are important for regulation of a number of physiological processes, including antibiotic synthesis, plasmid transfer, and expression of virulence factors (367) .
During endoscopy, the environment provides optimal conditions for contamination and subsequent growth of biofilms. Modern flexible endoscopes contain multiple channels and ports which can easily collect organic material. Even if valid endoscope reprocessing protocols are applied, microbial accumulation can lead to development of a biofilm inside narrow endoscope channels over time (89) . Biofilm formation on the inner surface of endoscope channels, especially when these become scratched or damaged, can result in failure of the decontamination process. It can create a vicious circle of growth, disinfection, partial killing or inhibition, and regrowth, resulting in outbreaks of endoscopyrelated infections in patients who underwent endoscopy with a biofilm-containing endoscope (2, 3) .
The presence of biofilms on the inner surface of endoscope channels has been reported in the literature (2, 89) . An outbreak of post-ERCP sepsis with multiresistant P. aeruginosa was related to biofilm development inside endoscope channels (2) . Three outbreaks of postendoscopic infection and cross-contamination were attributed to contaminated AERs with the presence of biofilm deposits on the internal plumbing and detergent tank (23, 25, 26) . Cross-contaminations of M. chelonae and M. mesophilicum resulted in colonization of patients after endoscopy with no infectious complications (25) . Reported infections in two other outbreaks included post-ERCP P. aeruginosa bacteremia/sepsis and cholangitis (23) and sepsis and pneumonia after bronchoscopy (26) .
Biofilms can be removed from artificial surfaces by physical and chemical methods (368) . Physical methods such as ultrasound and manual cleaning are generally effective but difficult to control in practice. Chemical methods can be unsuccessful because of the resistance of biofilms to antibiotics, disinfectants, and biocides (363) . The cleaning process is most critical for biofilm removal because multiple internal channels of flexible endoscopes cannot be inspected for cleanliness. The cleaning product must show good penetration and solubilization of organic debris and biofilms. In a study reported by Vickery et al. (368) , enzymatic cleaners failed to reduce viable bacterial numbers more than 2 logs in E. coli biofilms in polyvinyl chloride tubing. Another study reported the failure of a commonly used enzymatic cleaner to completely remove test soil from endoscope channels (369) . Nonenzymatic detergents showed a better inhibition of biofilm formation than enzymatic detergents (368, 370) . The most efficient methods for biofilm removal were autoclaving and treatment with a concentrated bleach solution (49) . High-temperature treatments (80°C to 90°C) were not effective for biofilm removal.
The use of antibiofilm-oxidizing agents with an antimicrobial coating inside washer disinfectors could reduce biofilm buildup inside endoscopes and AERs and decrease the risk of transmitting infections (15, 49) . Sterilization can be helpful to destroy microorganisms within biofilms. However, ethylene oxide sterilization may fail in the presence of organic debris after an inadequate cleaning procedure before reprocessing of flexible endoscopes (16, 17) .
MICROBIOLOGICAL SURVEILLANCE OF ENDOSCOPE REPROCESSING
Routine microbiological testing for endoscopes and AERs remains a controversial issue in many guidelines. Microbiological surveillance of endoscope reprocessing has been recommended by several medical specialist organizations (371) (372) (373) . It is appropriate to trace contaminations of endoscopes and to prevent contaminations and infections in patients after endoscopic procedures (2, 3) . The use of environmental endoscope culturing is a rapid and simple method to monitor the effectiveness of standard reprocessing procedures (374) . Other organizations recommend microbiological surveillance of flexible endoscopes only in response to epidemiologic investigations when instruments may be microbial sources of health care-associated disease transmission or in the case of testing the effectiveness of new or modified cleaning or disinfection procedures (375) . Microbiological surveillance sys-tems have several important limitations. If there is a clinical demand for the reuse of an endoscope, surveillance culture results will not be obtained until after the endoscope is used on the next patient, because culture results take a minimum of 24 to 48 h to be produced (371) . Efficient sampling of flexible endoscopes and their accessories may be hindered by a complex design, materials, construction, and fragility or by the absence of a standardized sampling protocol or an appropriate technique for sampling of the surfaces and channels of the flexible endoscope (375) .
Some techniques are recommended for microbiological sampling of flexible endoscopes (375) . A swab-rinse technique should be used for sampling the exterior surfaces and the distal opening of the suction-biopsy channel port. For adequate sampling of the inferior surface of endoscope channels, a "flush/brush/flush" technique should be performed with rinsing through the channel with a sterile fluid and using a sterile cleaning brush to obtain samples from the biopsy port. A simple flushthrough technique may be considered when brushing of the channel lumens is impossible, but it is less efficient (375) .
According to the literature, endoscopes can be sampled in an anterograde and retrograde manner. For anterograde sampling, the last-rinse water from the endoscope is collected inside the washer-disinfector at the distal end of the endoscope (3, 9) . For retrograde sampling, the suction-biopsy channel and the air-water channel of the endoscope are each flushed with 20 ml sterile demineralized water manually outside the AER from the distal to the proximal end. According to the literature, anterograde sampling is not sensitive enough (3, 9) . Endoscope culturing with a retrograde technique is effective for monitoring endoscope reprocessing, and testing is easy to perform (3). Introduction of new techniques that are easier to perform on a daily basis and with faster results may improve the microbiological surveillance of endoscope reprocessing. New methods may be based on direct ATP measurement or quantitative PCR. These methods must be further optimized because of their low specificity (376, 377) .
The literature provides no standards for the frequency of testing intervals of surveillance cultures. The Gastroenterological Society of Australia guideline recommends microbiological monitoring of duodenoscopes, bronchoscopes, and AERs every 4 weeks and all other GI endoscopes every 4 months (372) . According to the European Society of Gastrointestinal Endoscopy guideline, routine microbiological testing of endoscopes is advised to be performed at intervals of no longer than 3 months (371). The use of routine environmental microbiological testing of therapeutic endoscopes once a month and diagnostic endoscopes once every 3 months has been reported (2, 3) .
A contaminated endoscope should be inspected for potential defects. Unfortunately, it is not possible to adequately check all internal endoscope channels. Any small damage can be the source of bacterial contamination within the scope, which is difficult or impossible to detect by routine inspection and testing (2, 3) . Some investigators have begun to explore sterile-sheathed endoscopes with new technology to reduce the risk of infectious complications (9, 378) . The EndoSheath, for instance, is an endoscope system in which all parts of the endoscope that come into contact with the patient are fully disposable.
Literature related to the costs associated with endoscope reprocessing and economic consequences of endoscope contamination is very limited. Economic evaluation of exogenous endoscopyrelated outbreaks should include an analysis of outcomes (num-ber of prevented iatrogenic infections) and an estimation of the health care, non-health care, and indirect costs (78) . A recently reported study analyzed the cost of 4-weekly surveillance microbiological tests of bronchoscopes, duodenoscopes, and AERs during a 5-year period (379) . The overall annual cost of microbiological testing and cost in time for nursing staff to collect the samples was estimated to be $13,339. Another study calculated the annual costs of surveillance of endoscope reprocessing (cost of microbiological testing and cost in time for staff) to be $33,959 (18) . It was also estimated that the cost of the post-ERCP outbreak of P. aeruginosa sepsis affecting six patients, i.e., direct health care costs for diagnosis, treatment, and hospitalization of six affected patients, was approximately $206,273 (18) .
CONCLUSION
Contaminated endoscopes have been linked to many outbreaks of device-related nosocomial infections. The true incidence of endoscopy-related infections is unknown because of inadequate surveillance or no surveillance at all. Endoscopy-related infections can cause serious harm and can give rise to concerns over these procedures by physicians and patients. Flexible endoscopes can be cleaned and disinfected but not sterilized after use. This implies the risk of settlement of biofilm-producing species.
Process control of the cleaning and disinfection procedure does not guarantee prevention of biofilm formation during endoscopy. Implementation of microbiological surveillance of endoscope reprocessing is appropriate to detect early colonization and biofilm formation in the endoscope and to prevent contamination and infection in patients after endoscopic procedures. However, the returns of prevention of endoscopy-related infections should be reasonably in balance with costs of technical and laboratory procedures resulting from surveillance and the costs of reprocessing or servicing of the contaminated endoscope.
